Dashboard
1
The company has declared Negative results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at USD -3.97 MM
- ROCE(HY) Lowest at -47.37%
- INVENTORY TURNOVER RATIO(HY) Lowest at 4.18 times
2
Risky - Negative EBITDA
3
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
USD 34 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.03
-43.93%
2.60
Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Mar 2025)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.7%
0%
-8.7%
6 Months
-5.62%
0%
-5.62%
1 Year
-15.66%
0%
-15.66%
2 Years
-30.12%
0%
-30.12%
3 Years
-29.53%
0%
-29.53%
4 Years
90.91%
0%
90.91%
5 Years
236.0%
0%
236.0%
Precision Optics Corp., Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.85%
EBIT Growth (5y)
-225.71%
EBIT to Interest (avg)
-1.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
1.45
Tax Ratio
0.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
21.02%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.76
EV to EBIT
-6.47
EV to EBITDA
-6.73
EV to Capital Employed
2.82
EV to Sales
2.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-43.59%
ROE (Latest)
-43.93%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 4 Schemes (10.78%)
Foreign Institutions
Held by 3 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
4.20
4.50
-6.67%
Operating Profit (PBDIT) excl Other Income
-2.00
-0.90
-122.22%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.10
-1.00
-110.00%
Operating Profit Margin (Excl OI)
-486.90%
-201.00%
-28.59%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is -6.67% vs 7.14% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is -110.00% vs 23.08% in Dec 2024
Annual Results Snapshot (Consolidated) - Jun'24
Jun'24
Jun'23
Change(%)
Net Sales
19.10
21.00
-9.05%
Operating Profit (PBDIT) excl Other Income
-2.50
-0.40
-525.00%
Interest
0.20
0.20
Exceptional Items
0.00
0.70
-100.00%
Consolidate Net Profit
-3.00
-0.10
-2,900.00%
Operating Profit Margin (Excl OI)
-142.60%
-30.30%
-11.23%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2024 is -9.05% vs 33.76% in Jun 2023
Consolidated Net Profit
YoY Growth in year ended Jun 2024 is -2,900.00% vs 88.89% in Jun 2023
About Precision Optics Corp., Inc. 
Precision Optics Corp., Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






